{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:13:30Z","timestamp":1793884410395,"version":"4.7.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective risk stratification is essential for guiding treatment decisions in patients with metastatic renal cell carcinoma (mRCC). The Meet-URO score is a novel prognostic model that integrates the International Metastatic RCC Database Consortium (IMDC) criteria with neutrophil-to-lymphocyte ratio (NLR) and the presence of bone metastases. Developed in the immunotherapy era, it has demonstrated superior prognostic accuracy compared to the IMDC score across various clinical settings and treatment strategies. Its validation in the context of first-line immune-based combinations has been awaited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>External validation of Meet-URO was performed using a large retrospective real-world cohort of mRCC patients treated with first-line immune-based combinations. Secondary analyses included a comparison with the IMDC score for predicting overall survival (OS) and progression-free survival (PFS). Additionally, restricted mean survival time (RMST) was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,418 patients were included in the analysis: 54% received ICI\u2013ICI regimen (nivolumab plus ipilimumab), while 46% received the ICI\u2013TKI combination. At baseline, 52.5% of patients had an NLR \u2265 3.2, and 32% had bone metastases. After a median follow-up of 26.8\u2009months, the median OS and median PFS were 34.7 and 11.3\u2009months, respectively. Meet-URO demonstrated effective prognostic stratification, identifying patient groups with markedly different outcomes (median OS 11.5-51.4\u2009months; 3-year OS 26-66%; RMST 20.0-42.8\u2009months). Compared to IMDC, Meet-URO showed a significantly better OS (c-index 0.675 vs 0.643; \u0394c\u2009=\u20090.032, P\u2009&amp;lt;\u2009.001) and PFS (c-index 0.60 vs 0.58; P\u2009&amp;lt;\u2009.001) prediction performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Meet-URO demonstrated robust prognostic accuracy. Its integration into routine clinical practice and use as a stratification factor in clinical trials may support more personalized treatment strategies and enhance clinical trial design.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag203","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:49:13Z","timestamp":1778845753000},"source":"Crossref","is-referenced-by-count":4,"title":["Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations"],"prefix":"10.1093","volume":"31","author":[{"given":"Sara Elena","family":"Rebuzzi","sequence":"first","affiliation":[{"name":"Medical Oncology Unit 2, Ospedale Molinette, Azienda Ospedaliero-Universitaria Citt\u00e0 della Salute e della Scienza di Torino , Torino, 10126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruni","family":"Ghose","sequence":"additional","affiliation":[{"name":"Barts Cancer Centre, Barts Health NHS Trust , London, EC1A 7BE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rudman","sequence":"additional","affiliation":[{"name":"Cancer Centre at Guy\u2019s, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London, SE1 9RT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde , Glasgow, G12 0YN,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Royal Marsden NHS Foundation Trust , London, SW3 6JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky Dylan","family":"Frazer","sequence":"additional","affiliation":[{"name":"Velindre Cancer Centre, Velindre University NHS Trust , Cardiff, CF14 2TL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubukola","family":"Ayodele","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre, University Hospitals of Leicester NHS Trust , Leicester, LE1 5WW,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stares","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, NHS Lothian, Western General Hospital , Edinburgh, EH4 2XU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"O\u2019Carrigan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cambridge University Hospitals NHS Foundation Trust , Cambridge, CB2 0QQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Oncology, United Lincolnshire Hospitals NHS Trust , Lincoln, LN2 5QY,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McGrane","sequence":"additional","affiliation":[{"name":"Sunrise Oncology Centre, Royal Cornwall Hospitals NHS Trust , Cornwall, TR1 3LJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Jain","sequence":"additional","affiliation":[{"name":"Deanesly Centre for Cancer Services, The Royal Wolverhampton NHS Trust , Wolverhampton, WV10 0QP,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Fiala","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University Prague , 323 00,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwani","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Barts Cancer Centre, Barts Health NHS Trust , London, EC1A 7BE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Michael","sequence":"additional","affiliation":[{"name":"Royal Surrey Cancer Centre, Royal Surrey NHS Foundation Trust , Guildford, GU2 7XX,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Zarkar","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Hospitals Birmingham NHS Foundation Trust , Birmingham, B15 2GW,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kapur","sequence":"additional","affiliation":[{"name":"Department of Oncology, Norfolk and Norwich University Hospitals NHS Foundation Trust , Norwich, NR4 7UY,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Charnley","sequence":"additional","affiliation":[{"name":"Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust , Preston, PR2 9HT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Afshar","sequence":"additional","affiliation":[{"name":"Department of Oncology, St George\u2019s University Hospitals NHS Foundation Trust , London, SW17 0QT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salil","family":"Vengalil","sequence":"additional","affiliation":[{"name":"Cancer Centre, Royal Stoke University Hospital, University Hospital of North Midlands NHS Trust , Stoke on Trent, ST4 6QG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Forde","sequence":"additional","affiliation":[{"name":"Northern Ireland Cancer Centre, Belfast Health and Social Care Trust , Belfast, BT9 7JL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Brown","sequence":"additional","affiliation":[{"name":"Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield, S10 2SJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u00fcksel","family":"\u00dcr\u00fcn","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara University Cancer Research Institute , Ankara, 06590,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Bianchini","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust , Maidstone, ME16 9QQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bahl","sequence":"additional","affiliation":[{"name":"Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust , Bristol, BS2 8ED,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanan","family":"Srihari","sequence":"additional","affiliation":[{"name":"Lingen Davies Cancer Centre, Shrewsbury and Telford Hospital NHS Trust , Shrewsbury, SY3 8XQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2173-8245","authenticated-orcid":false,"given":"Fabrizio","family":"Di Costanzo","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Centre for Cancer, Newcastle University , Newcastle upon Tyne, NE2 4HH,","place":["United Kingdom"]},{"name":"Medical Oncology, University of Naples Federico II , Naples, 80131,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Smalley","sequence":"additional","affiliation":[{"name":"Department of Oncology, Portsmouth Hospitals University NHS Trust , Portsmouth, PO6 3LY,","place":["United Kingdom"]},{"name":"Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth , Portsmouth, PO1 2DT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Parkes","sequence":"additional","affiliation":[{"name":"Worcestershire Oncology Centre, Worcestershire Acute Hospitals NHS Trust , Worcester, WR5 1DD,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Crabb","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Hospital Southampton NHS Foundation Trust , Southampton, SO16 6YD,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Vasudev","sequence":"additional","affiliation":[{"name":"Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust , Leeds, LS9 7TF,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Poprach","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University , Brno, 656 53,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Brown","sequence":"additional","affiliation":[{"name":"Cancer Centre at Guy\u2019s, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London, SE1 9RT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijo","family":"James","sequence":"additional","affiliation":[{"name":"Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde , Glasgow, G12 0YN,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Haywood","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Royal Marsden NHS Foundation Trust , London, SW3 6JJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Tapia","sequence":"additional","affiliation":[{"name":"Velindre Cancer Centre, Velindre University NHS Trust , Cardiff, CF14 2TL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Vijay","sequence":"additional","affiliation":[{"name":"Leicester Cancer Research Centre, University Hospitals of Leicester NHS Trust , Leicester, LE1 5WW,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Parry","sequence":"additional","affiliation":[{"name":"Edinburgh Cancer Centre, NHS Lothian, Western General Hospital , Edinburgh, EH4 2XU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cambridge University Hospitals NHS Foundation Trust , Cambridge, CB2 0QQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishika","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Oncology, United Lincolnshire Hospitals NHS Trust , Lincoln, LN2 5QY,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall O","family":"Moon","sequence":"additional","affiliation":[{"name":"Sunrise Oncology Centre, Royal Cornwall Hospitals NHS Trust , Cornwall, TR1 3LJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Abrol","sequence":"additional","affiliation":[{"name":"Deanesly Centre for Cancer Services, The Royal Wolverhampton NHS Trust , Wolverhampton, WV10 0QP,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Tkadlecov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University Prague , 323 00,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin Shwe Yee","family":"Soe","sequence":"additional","affiliation":[{"name":"Royal Surrey Cancer Centre, Royal Surrey NHS Foundation Trust , Guildford, GU2 7XX,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Zargham","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Hospitals Birmingham NHS Foundation Trust , Birmingham, B15 2GW,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Oncology, Norfolk and Norwich University Hospitals NHS Foundation Trust , Norwich, NR4 7UY,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ashley","sequence":"additional","affiliation":[{"name":"Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust , Preston, PR2 9HT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Hardy","sequence":"additional","affiliation":[{"name":"Department of Oncology, St George\u2019s University Hospitals NHS Foundation Trust , London, SW17 0QT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grisma","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Oncology, St George\u2019s University Hospitals NHS Foundation Trust , London, SW17 0QT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw Kyaw","family":"Tun","sequence":"additional","affiliation":[{"name":"Cancer Centre, Royal Stoke University Hospital, University Hospital of North Midlands NHS Trust , Stoke on Trent, ST4 6QG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Johnston","sequence":"additional","affiliation":[{"name":"Northern Ireland Cancer Centre, Belfast Health and Social Care Trust , Belfast, BT9 7JL,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Sarwer","sequence":"additional","affiliation":[{"name":"Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield, S10 2SJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"B\u00f6lek","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara University Cancer Research Institute , Ankara, 06590,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshani","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust , Maidstone, ME16 9QQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarnath","family":"Challapalli","sequence":"additional","affiliation":[{"name":"Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust , Bristol, BS2 8ED,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Meegan","sequence":"additional","affiliation":[{"name":"Lingen Davies Cancer Centre, Shrewsbury and Telford Hospital NHS Trust , Shrewsbury, SY3 8XQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobana","family":"Anpalakhan","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Hospital Southampton NHS Foundation Trust , Southampton, SO16 6YD,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Buono","sequence":"additional","affiliation":[{"name":"Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust , Leeds, LS9 7TF,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kolarikova","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University , Brno, 656 53,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Ka-Wai","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong , Hong Kong,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Murianni","sequence":"additional","affiliation":[{"name":"S.C. Oncologia, Ospedale \u201cBorea\u201d di Sanremo, ASL1 Imperiese , Sanremo, 18038,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Catalano","sequence":"additional","affiliation":[{"name":"S.C. Oncologia, Ospedale \u201cBorea\u201d di Sanremo, ASL1 Imperiese , Sanremo, 18038,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Bimbatti","sequence":"additional","affiliation":[{"name":"Oncology Unit 1, Istituto Oncologico Veneto\u2014IOV IRCCS , Padova, 35128,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Buti","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, University Hospital of Parma , Parma, 43126,","place":["Italy"]},{"name":"Department of Medicine and Surgery, University of Parma , Parma, 43125,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-9144","authenticated-orcid":false,"given":"Alessio","family":"Signori","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genova , Genova, 16132,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fornarini","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino , Genova, 16132,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Rescigno","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Centre for Cancer, Newcastle University , Newcastle upon Tyne, NE2 4HH,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Yuen Chun","family":"Teoh","sequence":"additional","affiliation":[{"name":"Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong , Hong Kong,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Luigi","family":"Banna","sequence":"additional","affiliation":[{"name":"Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth , Portsmouth, PO1 2DT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026062512022371900_oyag203-B1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","article-title":"First and second-line treatments in metastatic renal cell carcinoma","volume":"87","author":"Barragan-Carrillo","year":"2025","journal-title":"Eur Urol"},{"key":"2026062512022371900_oyag203-B2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"2026062512022371900_oyag203-B3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology Guidelines on renal cell carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"2026062512022371900_oyag203-B4","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026062512022371900_oyag203-B5","doi-asserted-by":"publisher","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","article-title":"Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival","volume":"4","author":"Dudani","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026062512022371900_oyag203-B6","doi-asserted-by":"publisher","first-page":"17588359211036552","DOI":"10.1177\/17588359211036552","article-title":"Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)","volume":"13","author":"Rebuzzi","year":"2021","journal-title":"Published Correction Appears in Ther Adv Med Oncol"},{"key":"2026062512022371900_oyag203-B7","doi-asserted-by":"publisher","first-page":"17588359221079580","DOI":"10.1177\/17588359221079580","article-title":"Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib","volume":"14","author":"Rebuzzi","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"2026062512022371900_oyag203-B8","doi-asserted-by":"publisher","first-page":"100634","DOI":"10.1016\/j.esmoop.2022.100634","article-title":"Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program","volume":"7","author":"Rebuzzi","year":"2022","journal-title":"ESMO Open"},{"key":"2026062512022371900_oyag203-B9","author":"EAU Guidelines \u2013 Renal Cell Carcinoma","year":"2024"},{"key":"2026062512022371900_oyag203-B10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12967-024-05014-z","article-title":"Validation of the Meet-URO score in metastatic clear cell renal cell carcinoma patients receiving second or third-line tyrosine kinase inhibitors-immune checkpoint inhibitors combination therapy","volume":"22","author":"He","year":"2024","journal-title":"J Transl Med"},{"key":"2026062512022371900_oyag203-B11","author":"Rini","year":"2019"},{"key":"2026062512022371900_oyag203-B12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","article-title":"Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade","volume":"38","author":"Motzer","year":"2020","journal-title":"Cancer Cell"},{"key":"2026062512022371900_oyag203-B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10585-024-10327-w","article-title":"Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study","volume":"42","author":"Rizzo","year":"2024","journal-title":"Clin Exp Metastasis"},{"key":"2026062512022371900_oyag203-B14","author":"Rebuzzi","year":"2025"},{"key":"2026062512022371900_oyag203-B15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.annonc.2022.06.003","article-title":"In the phase III IMmotion151 trial of metastatic renal cell carcinoma the easy-to-implement modified Glasgow prognostic score predicts outcome more accurately than the IMDC score","volume":"33","author":"Saal","year":"2022","journal-title":"Ann Oncol"},{"key":"2026062512022371900_oyag203-B16","doi-asserted-by":"publisher","first-page":"114048","DOI":"10.1016\/j.ejca.2024.114048","article-title":"Validation of the lung immune prognostic index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma","volume":"204","author":"Carril-Ajuria","year":"2024","journal-title":"Eur J Cancer"},{"key":"2026062512022371900_oyag203-B17","doi-asserted-by":"publisher","first-page":"105238","DOI":"10.1016\/j.critrevonc.2026.105238","article-title":"When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinoma","volume":"221","author":"Buti","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026062512022371900_oyag203-B18","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.critrevonc.2021.103293","article-title":"Cytoreductive nephrectomy in the era of targeted- and immuno-therapy for metastatic renal cell carcinoma: an elusive issue? A systematic review of the literature","volume":"160","author":"Mazzaschi","year":"2021","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag203\/68345923\/oyag203.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag203\/68345923\/oyag203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag203\/68345923\/oyag203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:02:28Z","timestamp":1782403348000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag203\/8688186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6,6]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag203","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,20]]},"article-number":"oyag203"}}